Eyelid Diseases: Clinical Trials

403 trials for Eyelid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

244 completed, 81 unknown, 25 recruiting, 17 terminated. 197 Not applicable, 53 Phase 2, 49 Phase 4, 33 Phase 3, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable197Completed 112, Unknown 48, Recruiting 13, Terminated 7, Not yet recruiting 6, Withdrawn 6, Active not recruiting 2, Enrolling by invitation 2, Suspended 1
Phase 253Completed 35, Terminated 6, Unknown 6, Active not recruiting 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 449Completed 35, Withdrawn 4, Not yet recruiting 3, Unknown 3, Recruiting 2, Suspended 1, Terminated 1
Phase 333Completed 22, Unknown 7, Terminated 2, Recruiting 1, Withdrawn 1
Phase 110Completed 7, Unknown 2, Terminated 1
Early Phase 16Completed 2, Unknown 2, Recruiting 1, Withdrawn 1

Follow Eyelid Diseases: new trials by email Literature Review of Eyelid Diseases trials Research Report on Eyelid Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
brimonidine tartrate ophthalmic solution 0.025%, sterile balanced saline solution - Glaucoma, Glaucoma, Open-Angle
Phase 4Not yet recruitingTulane University602027-11-012026-10-13
Upneeq vs. Lumify Ptosis
Oxymetazoline 0.1% (Upneeq), Brimonidine 0.025% (Lumify) - Acquired Ptosis
Phase 4Not yet recruitingDuke University502026-12-012026-05-22
Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients
Meibomian Gland Dysfunction, Dry Eye Syndromes
Not yet recruitingAssiut University1502026-10-012026-09-09
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis.
Anterior white-line advancement using an ABSORBABLE suture (POLYSORB 5-0). RED CODE., Anterior white-line advancement using a NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE. - Blepharoptosis
Not applicableNot yet recruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz582026-10-012026-10-01
Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia
Omega-3 supplement, Warm compress, Standard eyelid cleanser - Pediatric Chalazia
Phase 2Not yet recruitingJaeb Center for Health Research1682026-10-012026-08-25
Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study
Repeated intravitreal anti-VEGF injection with eyelid speculum - Blepharoptosis, Age-Related Macular Degeneration
RecruitingAbdulkadir Küçük602026-09-252026-10-22
DaxibotulinumtoxinA for Blepharospasm
Botulinum Neurotoxin Type A - Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid
Phase 2RecruitingUniversity of Pennsylvania202026-09-242026-09-29
A Trial to Evaluate Two Ectropion Preventive Measures Using the Subciliary Approach in Orbital Fracture Surgery.
Subciliary Approach, Lateral Canthopexy, Orbicularis Oculi Suspension - Orbital Fractures, Orbital Floor Fractures
Not applicableNot yet recruitingMinia University302026-09-012026-08-20
A Real-Time Magnetic Device Prototype for Temporary Management of Paralytic Lagophthalmos
Magnetic device prototype - Paralytic Lagophthalmos
Not applicableSuspendedE-DA Hospital122026-08-012025-08-14
TearCare in Young Adults
TearCare® - Meibomian Gland Dysfunction (Disorder)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham452026-08-012026-05-11
The Effect of Eyelid Support Plate Assisted Eyelid Massage on Meibomian Gland Dysfunction: a Randomized Controlled Trial
eyelid support plate assisted eyelid massage, glass rod assisted eyelid massage - Dry Eye Disease (DED), MGD-Meibomian Gland Dysfunction
Not applicableNot yet recruitingZhongshan Ophthalmic Center, Sun Yat-sen University1422026-07-012026-06-11
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
Vevye(Cyclosporine 0.1% Ophthalmic Solution) - Meibomian Gland Dysfunction (MGD)
Phase 4RecruitingUniversity of Alabama at Birmingham482026-06-012026-06-09
Demodex Blepharitis in Scleral Lens Wearers
Xdemvy - Demodex Blepharitis
Phase 4CompletedBoston Sight62026-04-272026-10-22
TearCare MGX™ System With and Without Warming Hold
localized heat therapy - Meibomian Gland Dysfunction (Disorder)
Not applicableCompletedSight Sciences, Inc.212026-03-172026-06-05
Is the Use of a Steam Mask an Effective Treatment for Paediatric Chalazion in Comparison to Traditional Warm Compresses?
Steam device, Warm Compress - Chalazion
Not applicableRecruitingUniversity of Sheffield282026-03-102026-07-23
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
Varenicline 0.03Mg/Spray Nasal Soln - Dry Eye, Meibomian Gland Dysfunction
Phase 4RecruitingUniversity of California, Berkeley652026-03-062026-05-27
Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction
Dietary Supplement: Microbiome-targeted oral supplement, Placebo - Dry Eye, Evaporative Dry Eye Disease
Not applicableEnrolling by invitationVarol TUNALI1302026-03-012026-07-28
Blink Reminders and Meibomian Gland Loss in Digital Screen Users
Digital Blink Reminder Software (BlinkEasy), Visual Hygiene Education (20-20-20 Rule). - Dry Eye Syndromes, Meibomian Gland Dysfunction (Disorder)
Not applicableNot yet recruitingAsociación para Evitar la Ceguera en México282026-02-192026-02-27
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
Sham IPL, Active IPL - Chalazion
Not applicableNot yet recruitingLumenis Be Ltd.402026-02-042026-02-19
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
B-RAP, BLTR - Trachoma, Eye Diseases
Not applicableRecruitingUniversity of North Carolina, Chapel Hill10002026-01-132026-04-13

Showing 20 of 403. Sign in to see all of them.

Narrower conditions

Meibomian Gland Dysfunction (169)  ·  Dry Eye Syndromes (107)  ·  Blepharoptosis (72)  ·  Blepharitis (62)  ·  Blepharospasm (41)  ·  Chalazion (16)  ·  Entropion (15)  ·  Dystonia (14)  ·  Ectropion (13)  ·  Trichiasis (13)  ·  Torticollis (10)  ·  Cutis Laxa (9)  ·  Lagophthalmos (8)  ·  Eyelid Neoplasms (7)

Broader conditions

Eye Diseases (400)  ·  Lacrimal Apparatus Diseases (112)  ·  Pathological Conditions, Signs and Symptoms (49)  ·  Nervous System Diseases (41)  ·  Signs and Symptoms (38)  ·  Neurologic Manifestations (37)  ·  Neoplasms (30)  ·  Skin and Connective Tissue Diseases (26)  ·  Dyskinesias (22)  ·  Skin Diseases (21)  ·  Conjunctival Diseases (18)  ·  Infections (18)  ·  Mouth Diseases (18)  ·  Stomatognathic Diseases (18)

Interventions

Azithromycin (14)  ·  Botulinum Toxins, Type A (13)  ·  Intense Pulsed Light Therapy (12)  ·  Lubricant Eye Drops (7)  ·  Brimonidine Tartrate (5)  ·  Doxycycline (5)  ·  Ophthalmic Solutions (5)  ·  Dexamethasone (4)  ·  Lidocaine (4)  ·  Loteprednol Etabonate (4)  ·  Low-Level Light Therapy (4)  ·  Saline Solution (4)  ·  Sodium Chloride (4)  ·  Therapeutics (4)  ·  incobotulinumtoxinA (4)

Sponsors

Benha University (9)  ·  Lumenis Be Ltd. (8)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (8)  ·  Alcon Research (7)  ·  Massachusetts Eye and Ear Infirmary (7)  ·  Merck Sharp & Dohme LLC (7)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (7)  ·  University of Miami (7)  ·  Chulalongkorn University (6)  ·  Laboratoires Thea (6)  ·  Allergan (5)  ·  Sheba Medical Center (5)  ·  TearScience, Inc. (5)  ·  University of California, San Francisco (5)  ·  University of the Incarnate Word (5)

Countries

United States (161)  ·  China (37)  ·  United Kingdom (19)  ·  Canada (15)  ·  Israel (14)  ·  France (12)  ·  Spain (11)  ·  Germany (10)  ·  Italy (9)  ·  Brazil (8)  ·  Egypt (8)  ·  United Arab Emirates (8)  ·  Ethiopia (7)  ·  South Korea (7)  ·  Thailand (7)

Top investigators

Emily Gower, PhD (4)  ·  James Chelnis, MD (4)  ·  Srihari Narayanan, OD, PhD (4)  ·  Jaime Dickerson, PhD (3)  ·  Reza Haque, MD (3)  ·  Rolando Toyos, MD (3)  ·  Christy Stevens, OD (2)  ·  Ciro Costagliola, Full Professor (2)  ·  David Zadok, MD (2)  ·  James S Wolffsohn, PhD (2)  ·  Louis Tong, PhD (2)  ·  Lyndon Jones, PhD (2)  ·  Mark Hallett, M.D. (2)

Results publications

PMID 31589610, PMID 21450914, PMID 21450915, PMID 21450918, PMID 22953007, PMID 27096755, PMID 27698616, PMID 31125783, PMID 35965392, PMID 37285925, PMID 11097583, PMID 11311627, PMID 11861988, PMID 12063480, PMID 12786773, PMID 12888056, PMID 12930337, PMID 14762403, PMID 15029042, PMID 15871316, PMID 15878075, PMID 16534049, PMID 17106406, PMID 17172891, PMID 17216074, PMID 17394642, PMID 18040708, PMID 18412605, PMID 19085290, PMID 19458801, PMID 19668387, PMID 19744718, PMID 19794937, PMID 19901217, PMID 19941140, PMID 20126486, PMID 20489573, PMID 20689407, PMID 20712970, PMID 21051704, PMID 21138337, PMID 21257145, PMID 21398284, PMID 21450917, PMID 21520284, PMID 21993469, PMID 22159169, PMID 22180731, PMID 22180732, PMID 22256909

NIH funding

1UG1EY036891 (1), 2009 (1), 2015 (1), 2019 (1), R01EY029437 (1), R44EY019586 (1), U54TR001456 (1), UG1EY025992 (1), UG1EY025992-04S1 (1)